[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100658325":3},{"organization":4,"outcomesModule":7,"designInfo":19,"detailedDescription":25,"studyPopulation":18,"armGroups":26,"interventions":37,"overallOfficials":43,"centralContacts":47,"locations":18,"responsibleParty":57,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":73,"maxAge":18,"enrollmentInfo":74,"targetDuration":18,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":91,"whyStopped":18,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":18},{"fullName":5,"class":6},"University of Alabama at Birmingham","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":18},[9],{"measure":10,"description":11,"timeFrame":12},"Total Number of Enrolled Participants with Blood Pressure Control","The number of enrolled participants with blood pressure control","Time Frame: 12 weeks (3 months) from randomization",[14],{"measure":15,"description":16,"timeFrame":17},"Number of Participants in the Intervention with Patient-Reported Outcomes","The number of participants with completed qualitative interviews and surveys regarding intervention adherence and satisfaction.\n\nThe survey will assess intervention adherence and satisfaction using the following scales: Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and the Feasibility of Intervention Measure (FIM).\n\nThe AIM is a 4-item scale where the min. value per item is 1 and the max. value per item is 5. A higher total score indicates better acceptability while the lower total score indicates worse acceptability.\n\nThe IAM is a 4-item scale where the min. value per item is 1 and the max. value per item is 5. A higher total score indicates better appropriateness while the lower total score indicates worse appropriateness.\n\nThe FIM is a 4-item scale where the min. value per item is 1 and the max. value per item is 5. A higher total score indicates better feasibility while the lower total score indicates worse feasibility.","Time Frame: 24 weeks (6 months) from randomization",null,{"allocation":20,"interventionModel":21,"interventionModelDescription":18,"primaryPurpose":22,"observationalModel":18,"timePerspective":18,"maskingInfo":23},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":24,"maskingDescription":18,"whoMasked":18},"NONE","For all participants:1. Participants will receive information on the importance of measuring blood pressure and ways to improve blood pressure. 2. Participants will complete questionnaires describing current socioeconomic position, medical history and healthcare needs. 3. Participants will come in for three research clinic visits to get blood pressure measured 3 months after enrollment in this study, and 6 months after enrollment in this study.\n\nFor participants asked to measure blood pressure at home: 1. Measure blood pressure twice a day at home, following the instructions provided. The study will provide participants with the device and send text message reminders twice a week. Participants will return the device at study visit 3 months from now. 2. Following the instructions provided, participants will talk to a pharmacist over the phone weekly to discuss blood pressure and medications. All medication changes will be discussed with a collaborating physician. 3. Participants will complete questionnaires and interviews on satisfaction with the program.",[27,33],{"label":28,"type":29,"description":30,"interventionNames":31},"Remote Blood Pressure Monitoring + Telehealth","ACTIVE_COMPARATOR","Participants will undergo remote blood pressure monitoring and pharmacist led telehealth intervention for blood pressure management",[32],"Behavioral: Remote Blood Pressure Monitoring + Telehealth",{"label":34,"type":35,"description":36,"interventionNames":18},"Usual Care","NO_INTERVENTION","Participants receive usual care from providers to manage blood pressure",[38],{"type":39,"name":28,"description":30,"armGroupLabels":40,"otherNames":41},"BEHAVIORAL",[28],[42],"Intervention group",[44],{"name":45,"affiliation":5,"role":46},"Lama Ghazi, MD, PhD","PRINCIPAL_INVESTIGATOR",[48,53],{"name":49,"role":50,"phone":51,"phoneExt":18,"email":52},"Tammi Thomas","CONTACT","205-934-7839","tammithomas@uabmc.edu",{"name":54,"role":50,"phone":55,"phoneExt":18,"email":56},"Bernadette Johnson","205-934-7329","bajohnson@uabmc.edu",{"type":46,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Lama Ghazi","Principle Investigator",[61],{"name":62,"class":63},"National Heart, Lung, and Blood Institute (NHLBI)","NIH","100658325","monitoring-blood-pressure-at-home-and-pharmacy-telehealth-among-people-living-with-hiv-100658325",false,"NCT07849595","Monitoring Blood Pressure at Home and Pharmacy Telehealth Among People Living With HIV","REmote Blood Pressure Monitoring and Pharmacist-Led Telehealth Program in an Emergency Department Transitional Care Clinic","REMAP-BP-HIV","Inclusion Criteria:\n\n* Age ≥18 years\n* Ability to speak English\n* Seen at UAB's 1917 Dewberry Clinic or Vanderbilt's Comprehensive Care Clinic\n* Blood pressure at Clinic: Systolic BP ≥ 130 mmHg or Diastolic BP ≥ 80 mmHg\n* Have a cellphone with video capability\n\nExclusion Criteria:\n\n* Systolic BP ≥ 160 mmHg or Diastolic BP ≥ 100 mmHg (i.e. severe range hypertension (HTN) by the 2025 American College of Cardiology\u002FAmerican Heart Association BP guidelines) as they typically are referred to immediate treatment intensification. Since the prevalence of severe HTN is low (i.e.\\\u003C5%) in the US population, exclusion of these individuals will have only a small effect on the study.)\n* Lack of willingness or inability to provide written informed consent\n* Individuals who work overnight or second shift\n* History of known major arrhythmias\n* Currently pregnant or breastfeeding\n* Arm circumference \\>50 cm. \\*The upper limit for the largest BP cuff for oscillometric BP devices is typically 50-52 cm; data from the National Health and Nutrition Examination Survey, 2011-2016 indicated that \\\u003C1% of US adults have an arm circumference \\>50 cm, so this will have minimal effect on our study","ALL","18 Years",{"count":75,"type":76},572,"ESTIMATED","INTERVENTIONAL",[79],"NA","The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage participants' blood pressure is useful. The study will enroll 552 participants who are seen at the University of Alabama at Birmingham 1917 Dewberry Clinic and Vanderbilt Comprehensive Care Center. Half of the participants (276 patients) will be asked to measure blood pressure at home, and half of the participants (276 patients) will continue to receive usual care. Participants who measure blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 6 months.",[82,83],"Hypertension","Blood Pressure Monitoring",[85,86,87,88,89,90],"Cardiovascular diseases","Delivery of Health Care","Patient Care Management","Health Services Administration","Telemedicine","Vascular Diseases","NOT_YET_RECRUITING","2026-09-24",{"date":94,"type":95},"2026-09-30","ACTUAL",{"date":97,"type":76},"2027-02-01",{"date":99,"type":76},"2031-05-31",{"name":5,"class":6}]